;wherein R′ is selected from the group consisting of H, OH, CONH2, COCH3, R″ is selected from the group consisting of H, CH3, R′″ represents H or CH3, and X− is a pharmaceutically acceptable counterion."/>
公开/公告号US2011201653A1
专利类型
公开/公告日2011-08-18
原文格式PDF
申请/专利号US201113094575
申请日2011-04-26
分类号A61K31/44;A61K31/4425;A61P35;
国家 US
入库时间 2022-08-21 18:15:42